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Background: Parasite-host arms race is one of the key factors in the evolution of life. Most cellular life forms, in
particular prokaryotes, possess diverse forms of defense against pathogens including innate immunity, adaptive
immunity and programmed cell death (altruistic suicide). Coevolution of these different but interacting defense
strategies yields complex evolutionary regimes.
Results: We develop and extensively analyze a computational model of coevolution of different defense strategies
to show that suicide as a defense mechanism can evolve only in structured populations and when the attainable
degree of immunity against pathogens is limited. The general principle of defense evolution seems to be that hosts do
not evolve two costly defense mechanisms when one is sufficient. Thus, the evolutionary interplay of innate immunity,
adaptive immunity and suicide, leads to an equilibrium state where the combination of all three defense strategies is
limited to a distinct, small region of the parameter space. The three strategies can stably coexist only if none of them
are highly effective. Coupled adaptive immunity-suicide systems, the existence of which is implied by the colocalization
of genes for the two types of defense in prokaryotic genomes, can evolve either when immunity-associated suicide is
more efficacious than other suicide systems or when adaptive immunity functionally depends on the associated suicide
system.
Conclusions: Computational modeling reveals a broad range of outcomes of coevolution of anti-pathogen defense
strategies depending on the relative efficacy of different mechanisms and population structure. Some of the predictions
of the model appear compatible with recent experimental evolution results and call for additional experiments.Background
The arms race between pathogens and hosts is a major
force in evolution that is likely to have played key roles in
the origins of multicellularity and sexual reproduction,
among other biological phenomena [1-5]. In this race,
hosts (both prokaryotic and eukaryotic) have evolved a
broad repertoire of defense strategies, sometimes at the
expense of allocating substantial resources and genomic
space for defense functions [6-11]. Although a vast diver-
sity of defense mechanisms exists across different life
forms, the defense strategies can be generally classified
into three groups [12]: (i) innate immunity systems
that are based on recognition of conserved features of
pathogens; (ii) adaptive (acquired) immunity systems that* Correspondence: koonin@ncbi.nlm.nih.gov
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unless otherwise stated.provide enhanced efficiency through pathogen-specific
(Lamarckian-type) adaptive evolution [9,13,14]; and (iii)
suicidal systems that cause programmed cell death (PCD)
preventing further spread of the infection [15-17]. In
principle, the PCD strategy can be considered a form of
innate immunity given the apparent lack of specificity to
particular pathogens in this form of defense [18,19]. How-
ever, given the substantial differences between the out-
comes of immune response and programmed cell death
for host, we adhere to the threefold classification of
defense strategies for the purpose of the present analysis.
In prokaryotes, innate immunity involves, among other
forms, receptor masking, restriction-modification (R-M),
Argonaute-based RNAi-like machinery and DNA phos-
phorothioation systems [7,20-22]. Adaptive immunity
that until recently had been considered a distinctive
innovation in animals, is represented in prokaryotes byThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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chaea and many bacteria [23-25]. Suicide (PCD) mech-
anisms comprise toxin-antitoxin (TA) and abortive
infection (Abi) systems [26-28]. Although most of these
defense mechanisms are widely distributed across the
prokaryotic world, the prevalence of each class greatly
varies among taxa [7]. Moreover, genes encoding differ-
ent defense systems are often clustered in genomic
islands, suggesting that some of them might function in
association [7,29]. In particular, most CRISPR-Cas loci
as well as many R-M loci contain genes encoding pre-
dicted toxins, leading to the hypothesis of a functional
coupling between immunity and suicide or dormancy
[7,12,30,31]. The diversity, intricacy and patchy distribu-
tion of anti-pathogen resistance mechanisms imply a
highly complex evolutionary history so that unraveling the
causes for the presence or absence of particular defense
systems in individual taxa becomes a difficult task.
The fate of defense systems in a host population de-
pends on multiple factors and trade-offs that contribute
to the cost-benefit balance [32-35]. On the one hand,
the benefits of having such systems depend on their effi-
cacy and the frequency of infections. Efficacy itself is the
outcome of the evolutionary arms race with pathogens,
and in the case of CRISPR-Cas, mathematical modeling
suggests that the efficacy of protection negatively corre-
lates with virus diversity and host and virus effective
population sizes [36,37]. On the other hand, fitness costs
can vary for different systems and depend on physical
and ecological variables, such as temperature, the iden-
tity of the pathogens targeted by the resistance mecha-
nisms and the relevance of horizontal transfer for the
acquisition of beneficial genes [38-43]. Population struc-
ture also likely plays a role in the evolution of defense
systems, not only through the repercussions for the eco-
logical pathogen-host dynamics [44], but also via direct
and indirect effects on the efficacies of different forms of
defense [45]. Such effects are well illustrated by experi-
ments with a genetically engineered suicidal system in
Escherichia coli which proved to be a successful phage
defense mechanism in soft agar culture but not in liquid
medium [46]. Fully compatible conclusions on the essen-
tial, general role of population structure for the evolution
and maintenance of programmed cell death have been
reached by mathematical modeling [4]. Finally, pre-
existing resistance could affect the evolution of additional
defense systems [47]. Specifically, the question ‘Why
evolving two costly systems for a single task?’ applies to
the evolution of suicide in the presence of immunity,
especially because suicide can be interpreted as a
defense system with an infinite individual fitness cost.
Here we develop and analyze a computational model
aimed at understanding which types of defense mecha-
nisms evolve under distinct ecological conditions. Weexamine a scenario where hosts already possess some de-
gree of resistance to pathogens via innate immunity and
can evolve additional, costly immunity and/or suicide
mechanisms. By exploring a broad range of immune and
suicide efficacies in combination with variable degrees of
population structure (from a well-mixed population to a
fully structured population with no migration), simula-
tions reveal a spectrum of evolutionary behaviors charac-
terized by the acquisition of one, two or all three classes of
defense mechanisms. While population structure proves
critical for the evolution of cell suicide, acquisition of
immunity mostly depends on its efficacy. We also ex-
tended the model to investigate possible causes and
consequences of coupling between adaptive immunity
and suicide. Taken as a whole, these results provide
context to the co-occurrence of defense mechanisms in
nature.
Methods
The computational model of pathogen-host coevolution
We set out to model a population of hosts and patho-
gens embedded in an interaction network. Such a net-
work determines not only the local dispersion of the
pathogen but also the possible locations of a host’s off-
spring. In addition, long-range dispersion of hosts and
pathogens to random locations on the network is
allowed at certain mixing rates. As the long-range dis-
persion rates increase, the structured system gradually
gives way to a well-mixed one. Two types of interaction
networks were implemented: (i) a square grid resembling
a 2-dimensional spatial structure, and (ii) a community
network in which hosts are structured in a number of
tightly connected clusters (cliques) of a given size. In the
latter case, clusters other than self can only be accessed
through long-range dispersion of host and pathogen.
Only one host per site is allowed. For computational
purposes, the number of pathogens per site is limited to
1000 (although in practice such a high number is not
reached). In the community network, group sizes ran-
ging from 2 to 100 totally connected sites per group
were explored through separate simulations. The net-
work size, which determines the carrying capacity for
hosts in the simulations, is equal to 106.
Ecological and evolutionary dynamics come into play
through the following processes:
(1) Host reproduction at a rate g, which succeeds if a
randomly chosen neighbor site in the network is
empty. In such a case, a copy of the parent host is
placed in that site.
(2) Host death at a rate dhost
(3) Infection at a rate b * npath where npath is the
number of pathogens sharing the site with the host.
Infection immediately leads to three possible outcomes:
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(efficient immunity).
(3b) Host dies and no pathogen is produced (efficient
suicide).
(3c) Host dies and M pathogens are produced (efficient
infection).
The outcome of the infection depends on the immune
efficacies (pII for innate immunity, pAI for adaptive im-
munity, pCD for suicide) and it is decided a sequential
way: first, an innate immune response is tried. If it fails
(which occurs with probability 1 − pCD), adaptive im-
munity comes into play. Suicide can be attempted before
or after immunity; the differences between the two re-
gimes are addressed when relevant. Because either im-
munity, suicide or pathogen release occurs right after
the infection there is no reproduction or dispersion of
infected hosts.
(4) Pathogen degradation at a rate dpath.
(5) Pathogen diffusion to neighbor sites at a rate D.
(6) Population mixing: the contents of two randomly
chosen sites are swapped at rates rmixhost (for hosts)
and rmixpath (for pathogens). A fully structured
scenario is set by making both rates equal to zero in
the square grid network and to 0.01 in the community
network. Notice that the latter requires a (small) value
greater than zero in order to avoid total isolation of
groups, which would lead to a population dynamics
entirely driven by small-size effects, with fast and
permanent extinction of parasites and/or hosts in
separate groups.
The model is implemented through a simplified ver-
sion of the tau-leaping algorithm. First, a time step dt is
set by taking the inverse of the largest event rate and
multiplying it by 0.2; then per individual/per site prob-
abilities for host reproduction, host death, infection,
pathogen degradation and mixing events are calculated
as pevent = 1 − e
− rate × dt. Notice that, given our choice of
dt and the parameter values, the probability of the same
event affecting the same individual (host or pathogen)
more than once per time step is negligible. In the case of
diffusion the probability that a pathogen drifts a given
distance is taken from a Poisson distribution with mean
equal to D × dt. After calculating event probabilities, we
proceed through every site in the network in a random
order. At each site, host replication and death are tried
first, sequentially followed by infection, pathogen deg-
radation and pathogen diffusion. The number of patho-
gens that are degraded is chosen from a Poisson
distribution with mean pdegr × npath, where npath is the
number of pathogens in the site after the outcome of a
possible infection. The number of pathogens diffusing agiven distance is chosen in a similar way and their final
locations are independently decided. Once all sites have
been updated, a number of mixing events for hosts and
pathogens is drawn from a Poisson distribution with
mean pmix times the number of sites in the network.
Each mixing event is performed by randomly choosing
two sites and exchanging their (host or pathogen) con-
tents. This completes a cycle of the algorithm, which
continues by setting a new time step and iterating the
previous actions.
The population is initialized with suicide propensity
equal to zero. Each time a host replicates, mutations
leading to small changes in the suicide propensity of the
daughter cell can take place with probability μ. Muta-
tions are implemented by randomly choosing a value
from a uniform distribution in the interval (−ε, ε) and
adding that to the suicide propensity pCD. Suicide pro-
pensity is kept bounded between 0 and 1. The probabil-
ity of successful suicide is the product of the suicide
propensity and a parameter CDmax, which represents the
maximum possible efficacy for suicide. In the simula-
tions, parameters μ and ε take values 0.01 and 0.1, re-
spectively; the outcome of the simulation was shown to
be highly robust to changes in the values of these
parameters.
With respect to immunity, two or more classes of
hosts with constant values of pII and pAI compete for
fixation. Adaptive immunity (AI) is envisioned as a trait
that provides the host with enhanced immunity at an
additional cost. Under the assumption that there are dif-
ferent timescales for immune adaptation (fast) and gain/
loss of AI-associated genes (slow), it is possible to assign
a time-averaged efficacy to the adaptive immunity sys-
tem and therefore circumvent explicit modelling of its
“Lamarckian” adaptive dynamics. The immune efficacies
pII and pAI should be interpreted as effective parame-
ters, i.e. averages along an ecologically meaningful time-
span which is long enough to allow for a large number
of host-pathogen encounters but short compared to the
evolutionary timescales involved in the acquisition and
loss of innate and adaptive immunity systems. Mutations
leading to AI acquisition or loss are set to occur with prob-
ability λ = 0.001. The fitness cost of adaptive immunity, c,
is modeled as a death rate increase. This fitness cost is paid
even if adaptive immunity is not activated (notice that the
case where immune activation entails an additional fitness
cost is formally equivalent to the variant of the model ex-
plored in section “Programmed cell death dependent on
immunity”).
Simulations run for 4000 host generations or until hosts
or pathogens become extinct. As a preliminary step, an ex-
tensive exploration of the parameter space was carried out
in order to determine which parameter combinations
allow for long-term coexistence of pathogens and hosts.
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selected: g = 1.01, dhost = 0.01, M = 30, b = 1, dpath = 2, c =
0.2, D = 10. To test the robustness of the results, several
other parameter combinations within the coexistence
space were also tried, with no qualitative changes. Also,
ncreasing λ to 0.01 (so that mutation rates for suicide and
adaptive immunity are the same) or ε to 0.5 (so that the
effect of single mutations on suicide is larger) produced
neither qualitative nor significant quantitative differences
in the stationary state. Multiple combinations for parame-
ters pII, pAI, pCD and CDmax were explored; the depend-
ency of the results on their values is discussed along the
text and the actual values used to produce the figures
are specified in the figure captions. All simulations were
performed using a C++ implementation of the model and
the results were processed and analyzed with MATLAB
(version R2014a, © 2014 The MathWorks, Inc.).
Results
Evolution of suicide in the absence of adaptive immunity
In order to simplify analysis of the model, evolution of
suicide is considered first in the absence of adaptive im-
munity. To this end, all hosts are deprived of adaptive
immunity (and its associated cost) from the beginning of
the simulation and are not allowed to recover it. In these
conditions, altruistic suicide evolves if (i) the efficacy of
innate immunity is low or moderate, and (ii) the popula-
tion is spatially structured (Figure 1). The first of theseFigure 1 Evolution of altruistic suicide in the absence of adaptive imm
evolutionary process as a function on the efficacy of innate immunity and
suicide propensity. B shows results for varying immune efficacy in a fully st
weakening the population structure at a fixed immune efficacy equal to 0.2
0.2 and no mixing. Grey to red colors indicate the suicide propensity of a h
infected hosts. In this setting, the decision to commit suicide occurs beforeconditions is relaxed if suicide is only triggered once im-
munity has failed. In such a case, suicide becomes a
non-costly trait (there is no cost for committing suicide
if the host has no chance of survival). This arguably un-
realistic behavior disappears if an explicit fitness cost is
considered for suicide (for instance, an increased basal
mortality associated with accidental induction of suicide
in the absence of pathogen). Other parameters of the
model, such as the infection rate (b) or the pathogen off-
spring number M, are relevant to determine the regions
of the parameter space where hosts and pathogens can
coexist but their relevance for the evolution of suicide is
minor. Similar results were obtained with both the two-
dimensional model and the community model. The case
of different mixing rates for hosts and pathogens was
also explored, with the result that evolution of suicide is
much more sensitive to the long-range dispersion of
hosts. As an example, for an immune efficacy of 0.2, sui-
cide does not evolve if the host mixing rate is above 0.45
whereas the pathogen mixing rate can increase up to 9.0
without precluding suicide.
Figure 1D shows that evolution of altruistic suicide is
concomitant with the formation of persistent islands of
interacting individuals. The two-dimensional setting re-
veals that hosts self-organize in spatial islands that sur-
vive the longer the greater their suicide propensity. In
the absence of suicide, waves of pathogen periodically
clear out groups of hosts which cannot persist for a longunity. A, B, C: Average suicide propensity of a population after the
the population mixing rate. The color code in A indicates the mean
ructured population (mixing rate equal to 0). C shows the effect of
. D: Snapshots of the evolutionary process for an immune efficacy of
ost (as in the color bar in A), white denotes empty sites and black
immunity. Maximum suicide efficacy CDmax = 1.
Figure 2 Suicide after immunity failure is favored compared to
suicide before immunity. The color code, from red to blue, indicates
the relative contribution of suicide before and after immunity to the
total suicide propensity, provided that both strategies are equally
accessible to the host. Horizontal and vertical axes correspond to
different values of the immune efficacy and the cost of maintaining
suicide, respectively. Cases of ‘no suicide’ correspond to final suicide
propensities below 0.1. Fully structured population with maximum
suicide efficacy CDmax = 1.
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values, host islands become more and more “impermeable”
to the pathogen (i.e. suicide of the surface cells protects the
inside of the island from the pathogen) which promotes
persistence of such islands. In the two-dimensional setting,
this effect is accompanied by a tendency of islands with
high suicide propensity to grow and invade the available
space.
Complementary to the spatially extended setting, the
community model provides for exploration of the effect
of host group size on the evolution of altruistic suicide.
Under this model, hosts are placed in semi-isolated
groups of limited size that locally behave as well-mixed
populations, migration across groups taking place at a
low rate. For small groups (up to at least 20 hosts per
group), we did not find any relevant differences with re-
spect to suicide evolution, the results being similar to
those obtained in the two-dimensional grid. In contrast,
simulations show that suicide does not evolve if groups
contain about 100 hosts or more. For such large groups,
the adverse effect of within-group well-mixing is stronger
than the positive effect of the meta-population structure.
As a result, large groups with high degree of phenotypic
heterogeneity require internal structure to prevent exploit-
ation by ‘selfish’ hosts and maintain altruistic suicide as an
efficient defense mechanism.
Finally, we explored a scenario where the choice be-
tween suicide and immunity is a selectable trait. Suicide
before and suicide after immunity were treated as two
alternative strategies that evolve independently and are
equally accessible to the host. Under conditions that are
favorable to the evolution of suicide, suicide after im-
munity always outcompetes suicide before immunity so
that the final state of the population fully consists of
hosts in which suicide is triggered only when immunity
fails (Figure 2).
Evolution of adaptive immunity in the absence of suicide
We further explored evolution of adaptive immunity in
hosts with no suicide. In this setting, suicide propensity
is set to zero, and two classes of hosts, with and without
adaptive immunity, compete for the limited spatial
resources. Both classes of hosts have the same level of
innate immunity and only differ by the presence or ab-
sence of adaptive immunity the efficacy of which is kept
constant during the simulations. Figure 3 (A,B) shows
the final composition of the population as a function of
the immune efficacies of the competing hosts. Three
regimes can be observed: i) fixation of adaptive immun-
ity, ii) coexistence of hosts with and without adaptive
immunity, and iii) loss of adaptive immunity. Fixation of
adaptive immunity is only possible at moderate efficacies
of both innate and adaptive immunity. As intuitively
expected, poorly performing adaptive immunity is lostbecause its benefits do not compensate for the associated
fitness cost. In the other extreme, less intuitively, adaptive
immunity cannot be fixed if its efficacy is too high. In this
case, the concentration of pathogens becomes so low that
hosts lacking adaptive immunity can survive by taking
advantage of their higher fitness compared to the hosts
possessing adaptive immunity.
The effects of population structure and fitness cost on
the evolution of adaptive immunity are merely quantita-
tive. In particular, population structure favors adaptive im-
munity and reduces the minimum efficacy that is required
for it to reach fixation (Figure 3A). The likely causes of
this effect are discussed below. Not surprisingly, the asso-
ciated fitness cost has a direct effect on the maintenance
of adaptive immunity, with higher costs requiring higher
efficacy (not shown). This effect is especially pronounced
in a well-mixed population; in a structured population,
however, adaptive immunity can be fixed even at higher
costs.
Combined evolution of suicide and adaptive immunity
In the well-mixed system, suicide does not evolve and the
results are the same as those described in the previous
section for the case without suicide. In structured popula-
tions, the interaction of suicide and immunity results in a
complex behavior that yields different combinations of the
three defense mechanisms.
As schematically shown in Figure 4, different efficacies
of the innate and adaptive immunities, as well as differ-
ent values of the maximum suicide efficacy, give rise to
distinct evolutionary outcomes which can be organized
in a phase diagram with 6 regions (Figure 4 C, D).
Figure 3 Fixation of adaptive immunity only takes place for a certain range of immune efficacies. The evolutionary process takes place at
fixed values of innate and adaptive immune efficacies and the fraction of hosts with adaptive immunity is recorded in the stationary state. The.
x-axis corresponds to the (externally fixed) efficacy of the innate immunity; the y-axis to the (externally fixed) efficacy of adaptive immunity; the
color code indicates the fraction of hosts with adaptive immunity. Regions in red indicate fixation of adaptive immunity, while those in blue
denote its loss. Coexistence of hosts with and without adaptive immunity takes place in regions with lighter colors. The evolutionary process takes
place in (A) a well-mixed scenario, (B) a structured population without possibility of suicide, and (C, D) a structured population with the possibility of
evolving suicide, with a maximum suicide efficacies of CDmax = 0.3 (C) or CDmax = 1 (D).
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({IAD}) that typically corresponds to small and moderate
efficacies of the innate immunity and moderate efficacy of
the adaptive immunity, and only if there is also a limit on
the efficacy of suicide. When the efficacy of adaptive im-
munity exceeds a certain threshold, suicide no longer
evolves ({IA}). For even higher efficacies of adaptive im-
munity (I+{IA}), the evolutionary process gives rise to two
divergent classes: hosts with adaptive immunity coexist
with hosts that lack it, both exhibiting negligible suicide
propensities. Notably, in the narrow coexistence region
({ID} + {IAD}), both classes of hosts, those with and with-
out adaptive immunity, evolve high suicide propensities.
In this region, the efficacy of adaptive immunity systems
lies just below the threshold of fixation. In the long term,
however, populations within this region might end up los-
ing adaptive immunity (Figure 5). Finally, adaptive im-
munity is lost if either its efficacy is too low or the efficacy
of innate immunity is too high. In the former case ({ID}),
hosts evolve suicide as an additional defense mechanism;in the latter (I only), innate immunity is the only defense
mechanism of the population. Temporal dynamics for rep-
resentatives of each region are shown in Figure 5.
A comparison of the panels B, C, and D from Figure 3
makes it clear that evolution of suicide can preclude
fixation of adaptive immunity. Specifically, as suicide
evolves to higher efficacies (i.e. larger values of the par-
ameter CDmax), fixation of adaptive immunity becomes
restricted to an increasingly narrow region of the param-
eter space. Figure 4A, B shows how increasing CDmax
results in higher AI efficacies being required for AI fix-
ation and a concomitant shrinkage of the region in
which AI and suicide coevolve. A detailed analysis of
such instances reveals a transient two-stage dynamics
(Figure 5, {ID} and {ID} + {IAD}): first, adaptive immun-
ity spreads in the population getting relatively close to
fixation; subsequently, altruistic suicide evolves in a mi-
nority of hosts that lack adaptive immunity. Eventually,
these individuals pervade the population and adaptive
immunity is lost.
Figure 4 Coevolution of adaptive immunity and suicide in a structured population depends on the immune and suicide efficacies.
(A): Fraction of hosts with adaptive immunity in the stationary state of the evolutionary process, as a function of the AI efficacy (pAI, y-axis) and
the maximum suicide efficacy attainable (CDmax, x-axis). Red accounts for AI fixation, blue for AI loss. The II efficacy has been fixed to pII = 0.2.
(B): Suicide propensity evolved by majority hosts, in the same conditions as in A. Red accounts for high suicide propensities, blue for low or no
suicide. The double white line separates two regions for which the majority hosts differ, in accordance to panel A. Notice that the actual suicide
probability, pCD, is the product of the suicide propensity and the maximum suicide efficacy attainable, CDmax. (C, D): Phase diagrams for the combined
evolution of suicide and adaptive immunity in a structured population. I: innate immunity; A: adaptive immunity; D: suicide; brackets indicate
coevolution of traits within the same host; regions with a striped shading pattern present coexistence of hosts with different sets of
defense mechanisms.
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with the evolution of suicide. To this end, combined
immunity was defined as a measure of the combined
efficacy of innate and adaptive immunity. Because both
forms of immunity act sequentially and independently,
the combined immune efficacy pItot equals to 1 − (1 − pII)
(1 − pAI). Figure 6 shows the average suicide propensity
versus the combined immunity for a set of simulations
performed with different innate and adaptive immune
efficacies. When adaptive immunity is lost, the results
coincide with those obtained in the absence of adap-
tive immunity. Likewise, hosts with adaptive immunity
(either fixed or in coexistence) show suicide propen-
sities similar to those expected for equivalent immune
efficacies in the absence of adaptive immunity. There-
fore, it can be concluded that adaptive immunity does
not specifically affect evolution of suicide as a defense
mechanism.The results presented in this section remain qualita-
tively the same regardless of whether suicide is activated
before or after immunity, provided that a fitness cost for
maintaining suicide is included (with zero cost suicide
after immunity always evolves, whereas no changes are
observed for suicide before immunity). The average sui-
cide propensities might be slightly higher in the latter
case but the regions of the phase diagrams (Figure 4C,
D) remain similar.
Programmed cell death dependent on immunity
Prokaryotic adaptive immunity systems, in particular
CRISPR-Cas, encompass genes that are otherwise impli-
cated in cell suicide such as toxin nucleases. In an attempt
to shed light on the evolutionary factors behind such a
tight co-occurrence of immunity and suicide, we exam-
ined a scenario where activation of adaptive immunity can
lead to cell death and no pathogen production with
Figure 5 Evolutionary dynamics of defense mechanisms,
representatives of each of the six regions of the phase
diagram. Black: fraction of hosts with adaptive immunity; red:
average suicide propensity in hosts with adaptive immunity; blue:
average suicide propensity in hosts without adaptive immunity.
Maximum suicide efficacy has been fixed to CDmax = 0.3, values of pII
and pAI have been chosen from the phase diagram in Figure 4C to
represent each possible evolutionary outcome. Population structured
in a square grid with no mixing.
Figure 6 Adaptive immunity does not affect the evolution of
suicide. The effective immune efficacy combines the efficacies of
innate and adaptive immunities in a single parameter, so that results
can be compared to the case with no adaptive immunity (solid line).
Black circles correspond to instances that lead to the loss of adaptive
immunity; solid red circles are used for instances with fixation of
adaptive immunity; open red circles for hosts with adaptive immunity
in instances without fixation. Data collapsed for structured populations
with multiple values of pII and pAI; CDmax = 0.3.
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contribution to the suicide propensity of the form q * pAI.
Two alternative formulations of the total suicide probabil-
ity can be considered: on the one hand, if AI-dependent
cell death is not affected by the maximum suicide efficacy,
then pCDtotal = pCD + q * pAI * (1 − pCD); on the other
hand, if the maximum suicide efficacy CDmax also limits
AI-dependent cell death, then pCDtotal = pCD + q * pAI *
(CDmax − pCD). In both cases, relatively large values of q
are required to obtain significant contributions of adaptive
immunity to cell death. We studied the possible outcomes
of an evolutionary process where hosts can possess either
an adaptive immunity system which does not induce
suicide (q = 0, no AI-dependent suicide), or an adaptive
immunity system which does induce suicide (q = 0.5, sub-
stantial AI-dependent suicide), or no adaptive immunity.
The AI-independent suicide can evolve as described in the
preceding sections; the probability of mutations leading to
gain/loss of AI-dependent suicide was set at 0.001. The re-
sults shown in Figure 7 indicate that suicide-inducing im-
munity can be preferentially selected for in structuredpopulations under conditions such that (i) coevolution of
adaptive immunity and suicide is the expected evolution-
ary outcome and (ii) death induced by adaptive immunity
is not limited by CDmax. If AI-dependent death is limited
by CDmax, suicide-inducing adaptive immunity is transi-
ently favored early in the evolutionary process but be-
comes a neutral trait compared to “simple” AI as soon as
the probability of AI-independent suicide reaches values
close to CDmax. Finally, an adaptive immunity system that
does not induce cell death is selected for in regions that
are unfavorable to suicide evolution (this is also the case
in well-mixed systems).Immunity dependent on cell death mechanisms
A distinct cause of the coupling between immunity and
suicide could be that some of the functions performed
by suicide genes are required for the immunity system
to function as suggested, in particular, by the essentiality
of Cas2, a homolog of toxin nucleases, for the CRISPR-
Cas function [48], and presence of a number of other
putative toxins in the CRISPR-cas loci [7,12,49]. Func-
tional coupling between suicide and adaptive immunity
can be introduced into the model by making the efficacy
of adaptive immunity dependent on the suicide propensity.
A simple logistic relation was chosen for this dependence
Figure 7 Alternative models for the evolution of coupled suicide and immunity. Two types of AI systems are considered: one whose
activation can lead to cell death (suicide) with the probability q = 0.5, and another that only works as a standard immune mechanism (with no
induction of additional suicide). Mutations between both types occur with a small probability. The figure shows the relative fraction of hosts with
suicide-inducer AI in the stationary state (normalized by the fraction of hosts with any kind of AI, the value 0.5 has been assigned wherever hosts
with AI represent less than 10% of the population). The evolutionary process was simulated in a structured population with different values of the
innate and adaptive immune efficacies (pII and pAI), and a fixed value of the maximum suicide efficacy CDmax = 0.3. In A, the maximum suicide
efficacy only affects AI-independent suicide; in B, the maximum suicide efficacy limits all kinds of suicide, included suicide induced by AI. Panels
C and D correspond to a modified scenario where the efficacy of AI depends on the total degree of suicide according to a logistic formula;
in C there is no limitation on AI-induced suicide, whereas in D it is limited by CDmax. The red region in panel D (but not in other panels) is
also characterized by the absence of AI-independent suicide.
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parameter that determines the shape of the dependence
between suicide and adaptive immunity, and AImax is the
maximum possible value of pAI. For small suicide propen-
sities, the effective pAI is equal to AImax * pCD/kAI. If
pCD≫ kAI, the effective pAI tends to AImax. Given that
pCD only takes values smaller or equal to unity, the max-
imum value that pAIeff can take is AImax/(1 + kAI).
Functional coupling of adaptive immunity with suicide
could result in the evolution of suicide under conditions
where it would not normally evolve, e.g. in well-mixed
populations or at high effective immunity levels. More-
over, relatively weak coupling (kAI = 0.5) is sufficient to
observe these effects. To test whether functional coup-
ling can explain the tight genomic co-occurrence of
immunity and suicide genes, we use the logistic depend-
ence of pAIeff on pCDtotal with the possibility that adap-
tive immunity contributes to pCDtotal, as in the previous
section. Here we assume logistic dependence (functional
coupling) and allow the adaptive immunity system to
mutate between variants that do or do not induce add-
itional death (q = 0.5 and q = 0, respectively). The same
two cases as before, with CDmax limiting total suicide or
AI-independent suicide only, were explored. Simulations
for different values of AImax and pII (Figure 7C, D) show
that an adaptive immunity system that also induces
death is strongly promoted if the suicide induced by AI
is not limited by CDmax. Conversely, if such a limit is in
place, adaptive immunity systems that do not induce sui-
cide tend to be selected for, provided that there is some
degree of AI-independent suicide.Discussion
General considerations on the modeling approach
In real biological communities, the efficacy of innate and
adaptive immune systems is constrained by ecological
factors such as population size, structure and diversity.
The never-stopping arms race between hosts and patho-
gens sets a limit on the performance of defense strat-
egies, which is determined by the ability of the host to
keep the pace with pathogen escape mutations. In that
regard, studies on host-parasite local adaptation suggest
that parasites are usually ahead of hosts in this coevolu-
tionary arms race [50,51]. Accordingly, evolution of im-
mune systems is modeled here under the assumption that
they have a constant efficacy that is extrinsically deter-
mined by a multiplicity of factors that go beyond the con-
trol of the host. In this simple model, the evolutionary
process only determines the relative abundance of hosts
with and without a given type of immune systems in the
population. Nevertheless, even in this simple setting, the
combination of different immune efficacies, population
structure and long range dispersal leads to a complex
interplay between different evolutionary outcomes which
we aimed to explore here.
The notion of effective immune efficacies is valid under
the assumption that there are two well differentiated time-
scales: (i) a relatively fast timescale for the processes of
pathogen escape and host immune adaptation; (ii) a sig-
nificantly slower timescale for the evolution (gain/loss) of
defense mechanisms. Under this timescale separation, var-
iations in immune efficacy due to the former processes
can be considered transient perturbations around a time-
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evolutionary timescales. For the CRISPR-Cas system, this
assumption implies that the characteristic timescales of
viral proto-spacer mutation and host spacer incorporation
are substantially faster than the timescale of CRISRPR-Cas
loci gain/loss, an assumption that seems to be borne by
the available observations [24,52]. We note that, because
of timescale separation, the long term evolutionary dy-
namics of adaptive immunity can be studied by modeling
adaptive immunity as a sort of stronger “innate immunity”
with a higher cost. The same approximation would not be
valid, though, to study short term, fine grained coevolution
of hosts and parasites. A further limitation of our model
concerns the immediate resolution of the infection event
towards immunity, suicide or pathogen release. While this
approach is especially suitable for modeling lytic infec-
tions, it does not account for the effects of persistent
infections or milder parasites. In such cases, migration
and/or reproduction of infected hosts should be taken into
account, as well as possible differences in timing between
different defense mechanisms. Indeed, theoretical studies
in the former direction suggest that evolution of altruistic
defense traits is hindered when infected hosts conserve
some degree of reproductive ability [45].
The binary nature of the adaptive immunity trait in
our model captures the qualitative difference between
having and not having a functional CRISPR-Cas system.
In contrast, pathogen-induced cell death (suicide) is
modeled as a continuous trait such that, for a given host,
the suicide propensity is the probability that a host
attempts suicide when it becomes infected. Successful
suicide leads to the death of the host and no pathogen
release. Mutations affecting the suicide propensity can
be interpreted as the result of variations in the copy
number of toxin-antitoxins or other systems that con-
tribute to cell death. Because a genome may contain a
large number of loci involved in suicide [7], the relative
effect of single mutations on the net suicide propensity
are presumably small. By modeling programmed cell
death as a quantitative trait, we capture this gradual nature
of suicide evolution. Simulations explore the possibility
that suicide gradually evolves starting from a population
with zero suicide propensity. Provided that pathogens can
also counter suicide mechanisms by inhibiting them or
delaying their effect [6,53], it seems appropriate to include
a maximum efficacy for suicide which limits the probability
of successful suicide even if the suicide propensity is equal
to one.
Throughout this analysis, we observed that population
structure substantially affected the outcomes of pathogen-
host interaction and evolution of defense mechanisms. In
a structured population, hosts and pathogens are not ran-
domly mixed in a homogeneous environment. Population
structure can result from purely physical constraints (e.g.limited host and pathogen diffusion) or from the way indi-
viduals interact with each other (e.g. social networks). In
order to account for both possibilities, the model was
tested in two structured settings: a 2-dimensional grid
with limited diffusion and a community network in which
small groups of hosts closely interact with each other. The
results were closely similar in both settings, confirming
that population structure itself, regardless of its particular
origin and implementation, is the cause of the observed
behaviors.
Evolution of different types of immunity and suicide
As shown in the preceding sections, suicide only evolves
in structured populations for which long range dispersal
remains under a threshold rate. Why is population struc-
ture required for the evolution of suicide? As with other
altruistic traits, a host does not benefit from its own sui-
cide. Instead, it provides a benefit to its neighbors by
preventing the local spread of the infection. Therefore,
suicide can evolve only when there is phenotypic re-
latedness among neighbors [54,55]. In a structured
population, hosts with a high suicide propensity will be
likely surrounded by other suicide-prone hosts and ac-
cordingly receive indirect benefit from the suicide of
their neighbors [45]. Long-range dispersion, as well as
population mixing, would bring together hosts with
large and small suicide propensities. In a well-mixed
population, the latter take advantage of the former so
that suicide propensity becomes a disadvantage. From a
game theory perspective, this dynamics defines a social
dilemma where population structure allows altruistic
hosts (those with high suicide propensity) to beat selfish
ones (those with small suicide propensity) [56]. High
rates of long-range pathogen dispersal can also preclude
the evolution of suicide if local pathogen spread be-
comes irrelevant compared to the constant arrival of
pathogens from the outside. Multiple experimental stud-
ies in bacteria have shown that population structure
(low dispersal rate) is indeed essential for the evolution
of cooperative traits [57-59] and in particular altruistic
suicide [46,60]. It should be noted that, although not
considered in our model, horizontal gene transfer could
also promote evolution of altruistic suicide by increasing
phenotypic relatedness between neighboring hosts [61].
The results of the present model of suicide evolution re-
veal an antagonism between the ‘interests’ of hosts and
pathogens in structured populations whereby, while hosts
tend to evolve suicide, prevention of host death is the pre-
ferred strategy for the pathogen. Indeed, it has been shown
that experimental evolution of phages under conditions of
local dispersion leads to ‘prudent’ (less virulent) variants
of the virus, in contrast to the virulent forms evolved in a
well-mixed environment [46]. Theoretical work also sug-
gests that reduced virulence is the most likely evolutionary
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whereas intermediate dispersal rates can lead to high viru-
lence [62]. It is therefore plausible that, in structured popu-
lations, the host-pathogen arms race has a major effect on
the genes involved in cell death and its inhibition. Numer-
ous viruses indeed have evolved mechanisms preventing
host cell death, often by recruiting genes involved in host
suicide and turning them into competitive inhibitors of cell
death [63-65] or else via repair of the damage involved in
cell death [66].
Adaptive immunity provides a direct benefit to the
host organism that possesses the immune mechanism
and thus does not require population structure to evolve.
There are, however, instances when population structure
favors fixation of adaptive immunity through a mechan-
ism analogous to the one observed for altruistic suicide.
Due to limited pathogen dispersion, hosts can benefit
from the local decrease in pathogen abundance produced
by their neighbors’ adaptive immunity. In a structured
population, neighboring hosts are phenotypically corre-
lated, reinforcing the advantage of adaptive immunity and
contributing to its fixation. This effect could allow fixation
of adaptive immunity even under conditions where the
cost-benefit balance is not in its favor. On the other hand,
if the immune efficacy is too high, hosts with and without
adaptive immunity tend to coexist as the former generate
environments with low pathogen pressure. This result
resembles those obtained by previous theoretical stud-
ies on well-mixed populations, which predict lack of
fixation for highly effective immunity systems and possible
polymorphisms on the degree of immunity evolved by
hosts [67,68].
Joint modeling of suicide and adaptive immunity gives
rise to a distribution of evolutionary outcomes (a phase
space) that cannot be simply explained through separate
analysis of each of these defense mechanisms. For in-
stance, high suicide efficacies prevent fixation of adaptive
immunity not only in those regions where the cost-benefit
balance for adaptive immunity is slightly unfavorable (even
if fixation would occur in the absence of suicide by virtue
of population structure), but also in some regions where
this balance is favorable to adaptive immunity. There
seems to be a rule of thumb whereby hosts do not evolve
an additional, costly defense mechanism when one such
mechanism is sufficient for effective defense. The most ob-
vious manifestation of this simple principle is that, when
innate immunity is highly effective, no other defense
mechanisms evolve. Similarly, hosts with large suicide effi-
cacy overtake those with adaptive immunity provided that
the suicide propensity is greater than a threshold that
grows with the efficacy of adaptive immunity. Notwith-
standing this general trend, innate and adaptive immunity
systems appear to coexist in other regions of the phase
space. Such a coexistence is compatible with the recentexplicit experimental demonstration of the synergy be-
tween R-M and CRISPR-Cas in bacterial resistance to bac-
teriophages [69]. Finally, there is a region of moderate
immune and suicide efficacies where hosts take advantage
of a combination of all three defense mechanisms: innate
immunity, adaptive immunity, and suicide.
In an attempt to explain the tight connection between
the CRISPR-Cas systems and (predicted) toxin genes
[7,12,49], we explored the possible evolutionary advantage
of an AI system which also induces suicide with a given
probability. Such a coupled system can be advantageous if
(i) suicide itself is advantageous in those particular evolu-
tionary conditions and (ii) the efficacy of AI-associated
suicide exceeds that of other suicide mechanisms. The
same two conditions for the evolution of a coupled
AI-suicide system were identified in a modified model
that considers a small suicide propensity as a pre-requisite
for the evolution of effective adaptive immunity (i.e. when
components of the suicide machinery also contribute to
adaptive immunity).
Host suicide can potentially evolve either as an imme-
diate response to infection or as a means of last resort
after immunity mechanisms fail to stop pathogen
reproduction [12]. Intuitively, the second strategy would
appear advantageous, and indeed in our model, when
the two strategies evolve independently and then are
allowed to compete, “suicide after immunity failure
wins”. However, under a non-negligible cost of suicide,
the probabilities of it evolving before and after immunity
is tried are comparable. It is worth mentioning that, at
cost zero, the conditions for the evolution of suicide
after immunity become greatly relaxed. Thus, the cost of
suicide appears to be a key determinant of the evolution-
ary regime. Recent experiments with suicide-prone E.
coli have shown that at least when defense against highly
virulent phages is involved, the cost of suicide could be
quite low because the infected bacteria are moribund in
any case and have virtually no chance to propagate [60].
Conceivably, these experiments reflect the regime with
failing immunity and subsequent low-cost suicide.
Implications for coevolution of prokaryotic defense
mechanisms
Together with innate immunity systems, cell suicide
(programmed cell death) and adaptive immunity are
widespread defense mechanisms in prokaryotes although
adaptive immunity is far from being universal. Two inter-
pretations, not mutually exclusive, appear plausible:
(a) The efficacies of innate and adaptive immunity
systems in prokaryotes lie in the appropriate region
that allows for combined evolution of suicide and
adaptive immunity. This view is compatible with
the fact that adaptive immunity is not universal in
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related to ecological variables (e.g. adaptive
immunity is much more common in
hyperthermophiles compared to mesophiles). Such
a patchy distribution suggests that the mean
efficacy of adaptive immunity is close to the
boundary of the fixation region, with variation
among ecosystems determining whether a
particular host population maintains adaptive
immunity or loses it.
(b) Different defense mechanisms are geared to fight
different threats. Immunity systems might be highly
effective against certain threats but less proficient
against others. Suicide can serve as a defense
mechanism that acts on those threats against which
the immunity systems are less effective. This
scenario accounts for the pre-requisite of the
evolution of suicide revealed by the analysis of the
models, namely that immune efficacy has to be low
or moderate for suicide to evolve and vice versa.
Under both scenarios, population structure is required
for the evolution of suicide. This pre-requisite had been
previously proposed on the basis of experimental studies
with a genetically engineered, suicidal strain of E. coli
grown on agar plates [46] and is theoretically extended here
to a broader spectrum of population structures, suicide
efficacies and co-occurring immune mechanisms.
The presence of programmed cell death systems in the
great majority of prokaryotes strongly suggests that
structured populations are the rule in microbial ecosys-
tems [4]. Indeed, some kind of social interaction, such as
biofilm formation, is found on almost every bacterial
group, and more advanced forms of sociality, such as
quorum sensing, are often present in Proteobacteria and
Firmicutes [70-72]. However, the link between PCD and
sociality is complicated by the fact that toxin-antitoxin
and Abi are addictive selfish elements, so that their
abundance in bacteria and archaea is likely to be in part
dictated by this property rather than by any utility to the
host [26,27].
With respect to the presence of genes encoding (pre-
dicted) toxins in most if not all CRISPR-Cas loci, at least
two, not necessarily mutually exclusive interpretations
seem possible:
(a) The CRISPR-associated toxin genes contribute to
the suicide propensity of the cell, in such a way that
cells with CRISPR-Cas-toxin systems are more
effective in orchestrating suicidal responses than
those with “regular” suicide systems only.
(b) Suicide and adaptive immunity are functionally
coupled, so that it is impossible to maintain an
adaptive immunity system without previouslydeveloping other functionalities that involve suicide
propensity. Although, under our model, coupled
AI-suicide systems are not a necessary evolutionary
outcome arising from this requirement alone, this
could be the case if “regular”, non-AI-associated
suicide systems were unable to provide the cells
with the functionalities required to maintain a
working adaptive immunity system. This possibility
appears realistic given that evidence that Cas2 pro-
tein, a homolog of toxin nucleases, is essential for
the adaptation stage of the CRISPR response al-
though the nuclease activity of this protein appar-
ently is not required. Further investigation of the
molecular mechanisms that are responsible for the
adaptation step of the CRISPR-Cas adaptive im-
munity is expected to clarify the nature of coupling
between adaptive immunity and PCD.
Conclusions
Evolution of suicide as a defense mechanism is only pos-
sible if (i) the host population is structured and (ii) the de-
gree of immunity that the hosts can achieve by other
means is limited. The widespread nature of suicide systems
in prokaryotic genomes calls for a reconsideration of the
relative importance of population structure for genome
evolution.
Perhaps somewhat paradoxically, fixation of a costly
adaptive immunity system is precluded not only when the
innate immunity and suicide systems are highly effective
but also when adaptive immunity itself performs at a high
level. In such a case, hosts with and without adaptive
immunity coexist in an environment where the pathogen
is scarce (herd immunity effect).
Under the present model, the evolutionary interplay of
suicide, innate immunity and adaptive immunity leads to
an equilibrium state where the combination of all three
defense mechanisms is limited to a distinct region of the
parameter space. Such a region is smaller than it could
be expected from studying suicide and adaptive immun-
ity independently. This finding is consistent with the
general principle that hosts do not usually evolve two
costly defense mechanisms when one is sufficient.
There is, however, a range in the efficacies of suicide,
innate and adaptive immunity systems that leads to com-
bined evolution of suicide and adaptive immunity. This
outcome is possible only when none of these defense
systems is highly effective and requires some degree of
structure in the host population. Therefore, it can be
predicted that certain ecological factors such as pathogen
diversity and effective population sizes may indirectly pro-
mote the evolution of alternative defense systems through
limiting the effectiveness of prevailing ones.
Finally, coupled adaptive immunity-suicide systems
can arise under two distinct scenarios: first, if the AI-
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other suicide systems; second, if the adaptive immunity
component functionally depends on its associated suicide
component and such functionality cannot be provided by
independent suicide systems. Further research on the
molecular biology of CRISPR-Cas systems and their asso-
ciated toxin genes will be necessary in order to assess the
feasibility and contribution of each of these scenarios.
The results of the present analysis most directly apply to
the mechanisms of anti-pathogen defense in bacteria and
archaea. However, the conclusions on the coevolution of
different defense strategies suggest that the combination
of immunity and/or suicide systems of multiple kinds is a
general feature of evolving organisms. The patterns of
co-occurrence of these mechanisms depend on ecological
factors such as host and pathogen diversities and habitat
structure.
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